GlassScriptPhysician profile
Robert R Macdonald
NPI 1861417156
$3,257.35
in general payments reported to CMS, 2019-2025
23 companies · $1,759 in 2025
The $1,759 reported for 2025 was more than what 88% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $422 · 2020: $49.61 · 2021: $20.20 · 2022: $426 · 2023: $344 · 2024: $237 · 2025: $1,759.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,208 · Travel and Lodging: $1,131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,208.18 |
| Travel and Lodging | $1,131.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $1,590.81 | 2025 | |
| Regeneron Healthcare Solutions, INC. | $404.97 | 2019-2025 | Dupixent |
| Stryker Corporation | $227.20 | 2019-2025 | Audion Et Dilation System |
| Optinose US, INC. | $169.59 | 2019-2024 | |
| Glaxosmithkline, LLC. | $158.80 | 2022-2025 | Nucala |
| Genzyme Corporation | $92.50 | 2022-2025 | |
| Smith+Nephew, INC. | $71.38 | 2019-2023 | Rf20000 |
| Neurent Medical Limited | $63.66 | 2024-2025 | Neuromark Radiofrequency Console, Neuromark Device, Neuromark System |
| Genentech USA, INC. | $60.33 | 2019 | |
| Alk-Abello, INC | $54.34 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $53.78 | 2019-2020 | |
| Phadia US INC. | $39.64 | 2023-2024 | Immunocap |
| Kowa Pharmaceuticals America, INC. | $38.69 | 2022-2023 | Seglentis |
| Davol INC. | $37.33 | 2022-2023 | Arista Ah Flexitip |
| Merck Sharp & Dohme LLC | $32.50 | 2023 |
Show all 23 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arbor Pharmaceuticals, INC. | $26.67 | 2019 | |
| Itamar Medical INC | $23.07 | 2024 | Watchpatone |
| Ars Pharmaceuticals Operations, INC. | $23.00 | 2025 | Neffy |
| Acclarent, INC | $20.20 | 2021 | |
| Intersect Ent, INC. | $18.66 | 2019 | |
| Inspire Medical Systems, INC. | $18.57 | 2024 | Inspire |
| Kaleo, INC. | $16.71 | 2022 | |
| Bolder Surgical, LLC | $14.95 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Macdonald listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.